Avantor Sciences

Historical price data

Avantor Sciences operates as a critical enabler of the global life sciences ecosystem, providing the essential materials, equipment, and services upon which drug discovery and manufacturing depend. The company has evolved from its 1904 origins as a chemical supplier into a diversified, multi-billion-dollar enterprise through strategic acquisitions and organic growth, building a deeply embedded, recurring revenue model with high customer switching costs. Its strategy focuses on capitalizing on the growth of biologics and advanced therapies, expanding its high-value service offerings, and leveraging its global scale to serve customers across the continuum from research to commercial production.

An integrated ecosystem of mission-critical capabilities including single-use bioprocessing solutions, ultra-high-purity materials and chromatography, and value-added supply chain & regulatory services that support the entire drug development lifecycle.

Avantor competes with large, integrated players like Thermo Fisher Scientific and Danaher (Cytiva) in bioprocessing, as well as with global distributors. Its advantage stems from a unique combination of proprietary product portfolios, deep application expertise, and a globally scaled service and distribution network that creates sticky customer relationships.